Oral presentation shares head-to-head results for investigational combination pozelimab plus cemdisiran vs. ravulizumab in paroxysmal nocturnal hemoglobinuria Initial results for odronextamab in first ...
Research projects by Cameron University chemistry students were among the 250 undergraduate oral and poster presentations featured at the recent American Chemical Society Southwest Regional Meeting in ...
Undergraduate students from all disciplines are invited to submit a research abstract to the U of A's Undergraduate Research Week Poster Competition. Submissions are due by Jan. 21, 2025.
"Up until now, risk models in genomics have relied on broad categories that overlook the specific and unique genetic makeup of each individual," said Giordano Bottà, CEO of Allelica. "This innovation ...
Accepted by the FDA with a PDUFA Target Action Date of June 28, 2025- - Commercial Planning in Progress for 2025 Launch - - Late Breaker Poster Presentation ...
and Promising Preclinical Data with EP300/CBP Bromodomain Inhibitor OPN-6602 in Multiple Myeloma Opna Bio, a clinical-stage biopharmaceutical company focused on the discovery and development of novel ...